On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
The new online Learning Center with new content can still be found under the “Training” folder on ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...